558 filings
10-K
2023 FY
GTBP
GT Biopharma Inc
Annual report
26 Mar 24
5:00pm
8-K
GTBP
GT Biopharma Inc
1 Feb 24
GT Biopharma, Inc. Announces 1-for-30 Reverse Stock Split
12:15pm
8-K
GTBP
GT Biopharma Inc
21 Dec 23
Submission of Matters to a Vote of Security Holders
3:30pm
8-K
GTBP
GT Biopharma Inc
4 Dec 23
GT Biopharma Announces IND Submission
5:00pm
DEFA14A
GTBP
GT Biopharma Inc
6 Nov 23
Additional proxy soliciting materials
5:25pm
DEFA14A
yaz33c grth6gls3f
6 Nov 23
Additional proxy soliciting materials
5:23pm
8-K
n6oi4vcet9z9
22 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:55pm
8-K
is3wvharmqlm
5 Jul 23
Submission of Matters to a Vote of Security Holders
9:00am
DEFA14A
xm11 23yh8wky
5 May 23
Additional proxy soliciting materials
5:29pm
DEFR14A
3qmnk fj2iisum
5 May 23
Revised proxy
5:28pm
8-K
3a7ha2pqr7
4 May 23
GT Biopharma Names Charles J. Casamento to the Board of Directors
9:05am
8-K
7vef09ehypyiy9n
28 Feb 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
w7qa7
4 Jan 23
GT Biopharma, Inc. Announces $6.5 Million Registered Direct Offering
6:22am